Myovant Sciences Ltd. Share-based Payment Arrangement, Accelerated Cost
Myovant Sciences Ltd. reported Share-based Payment Arrangement, Accelerated Cost of $1.30 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2021-10-26
- Myovant Sciences Ltd. share-based payment arrangement, accelerated cost for the quarter ending 2021-09-30 was $1.30M.
- Myovant Sciences Ltd. share-based payment arrangement, accelerated cost for the quarter ending 2020-03-31 was -$8.40M.
- Myovant Sciences Ltd. share-based payment arrangement, accelerated cost for the quarter ending 2019-12-31 was $1.80M.
- Myovant Sciences Ltd. share-based payment arrangement, accelerated cost for fiscal 2020 was $1.80M, a 82.35% decline from fiscal 2019.
- Myovant Sciences Ltd. share-based payment arrangement, accelerated cost for fiscal 2019 was $10.20M.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2021-09-30 | $1.30M 10-Q · filed 2021-10-26 | $1.30M 10-Q · filed 2021-10-26 | ||
| 2020-03-31 | -$8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-18 | -$6.60M derived: sum of 2 quarters · filed 2021-02-11 | $1.80M 10-K · filed 2020-05-18 | |
| 2019-12-31 | $1.80M 10-Q · filed 2021-02-11 | $10.20M 10-Q · filed 2021-02-11 | ||
| 2019-03-31 | $10.20M 10-K · filed 2020-05-18 |